News

Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo ...
CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...
A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.
The mRNA metabolism passively shapes the levels of an mRNA modification called m6A within a steady-state cell and upon stress.
New imaging tools reveal how within an hour of infection, the virus begins to alter our chromosomes to kick-start its own replication.
STUTTGART, Germany I June 27, 2025 I La Merie Publishing announced the release of its newest technology market report about gene therapy technologies for in vivo expression of antibodies. The report ...
In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...
A pig gene edited to resist the PRRS virus has been approved for food use in the U.S. Approval in Canada will be a test of its new gene editing rules.
The H5N1 avian influenza virus has infected birds and mammals around the world. As of June 2025, 70 people have been infected ...
Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and diagnostic approaches are urgently needed. Emerging research highlights the ...